Invenomic Capital Management’s Diamond Hill DHIL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-9,388
Closed -$1.55M 147
2022
Q3
$1.55M Sell
9,388
-4,402
-32% -$780K 0.13% 128
2022
Q2
$2.39M Buy
+13,790
New +$2.45M 0.17% 115
2021
Q4
Sell
-16,660
Closed -$2.93M 150
2021
Q3
$2.93M Sell
16,660
-5,476
-25% -$958K 0.95% 38
2021
Q2
$3.7M Sell
22,136
-45
-0.2% -$7.71K 0.89% 24
2021
Q1
$3.46M Buy
22,181
+6,195
+39% +$953K 0.77% 24
2020
Q4
$2.39M Sell
15,986
-16,255
-50% -$2.37M 0.61% 33
2020
Q3
$4.07M Buy
32,241
+2,532
+9% +$309K 2.24% 7
2020
Q2
$3.38M Buy
29,709
+13,997
+89% +$1.47M 2.5% 3
2020
Q1
$1.42M Sell
15,712
-13,949
-47% -$1.76M 1.16% 29
2019
Q4
$4.17M Buy
+29,661
New +$4.15M 1.67% 15

Other funds holding DHIL

Invenomic Capital Management's DHIL Position: Q4 2022 in Review

Invenomic Capital Management sold out of Diamond Hill (DHIL) in Q4 2022, closing a stake of 9,388 shares — an estimated $1.55M sold.

Invenomic Capital Management first reported a position in DHIL in Q4 2019 and held it in 10 quarters. The position peaked at $4.17M in Q4 2019. 117 funds tracked by Wall St. Rank hold DHIL as of Q4 2022.

  • Invenomic Capital Management reported no remaining Diamond Hill position as of Q4 2022 after selling out during the quarter.
  • Invenomic Capital Management sold 9,388 Diamond Hill shares in Q4 2022, an estimated $1.55M.
  • Invenomic Capital Management first reported a position in Diamond Hill in Q4 2019 and held it in 10 quarters.
  • Invenomic Capital Management's Diamond Hill position peaked at $4.17M in Q4 2019.
  • 117 funds tracked by Wall St. Rank held Diamond Hill as of Q4 2022.

Based on Invenomic Capital Management's 13F filing for Q4 2022, filed 14 Feb 2023.